Skip to content

Rate Flow® L2590260-US5300Recalls & reported problems

Leventon Sau · Rate Flow® Regulator Extension Set with Rate Flow Regulator, ULTRASITE® Injection Site, and Spin-Lock® Connector · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
10
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 10 adverse event reports that list this exact device (DI 08436020767234), received between Oct 16, 2018 and Oct 16, 2018 — classified as 10 malfunctions.

The most frequently reported specific device problem is “Excess Flow or Over-Infusion” (10 reports).

1 other recall cover devices cleared under the same FDA submission (K851058); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Excess Flow or Over-Infusion10

Patient problems

  • No Consequences Or Impact To Patient8
  • No Patient Involvement2

Recent adverse event reports

The 10 most recent of 10 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 16, 2018Excess Flow or Over-Infusion; Excess Flow or Over-Infusion

    AS REPORTED BY USER FACILITY: EVENT 1. THE FLOW REGULATOR WAS SET TO INFUSE AT 250 ML/HR, WHICH SHOULD HAVE INFUSED OVER 4 HOURS, BUT THE IV FLUID RAN THROUGH IN JUST UNDER 2 HOURS. NO HARM TO THE PATIENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7969283 ↗
  • MalfunctionOct 16, 2018Excess Flow or Over-Infusion; Excess Flow or Over-Infusion

    AS REPORTED BY USER FACILITY: EVENT 2. AN "IN HOUSE" TEST OF THE PRODUCT USING A 1 LITER BAG OF FLUID AND THE SAME GRAVITY TUBING THAT IS BEING USED IN THE COMMUNITY WAS PERFORMED. CUSTOMER DID FOLLOW THE DIRECTIONS FOR SET UP OF THE SYSTEM INCLUDING HEIGHT REQUIREMENTS; ETC. THE FLOW REGULATOR WAS SET TO INFUSE AT 250 ML/HR; WHICH SHOULD HAVE INFUSED OVER 4 HOURS; BUT THE IV FLUID RAN THROUGH IN JUST UNDER 2 HOURS. NO PATIENT INVOLVEMENT.

    Patient problems: No Patient Involvement

    MAUDE report 7969280 ↗
  • MalfunctionOct 16, 2018Excess Flow or Over-Infusion; Excess Flow or Over-Infusion

    AS REPORTED BY THE USER FACILITY: EVENT 1. THE FLOW REGULATOR WAS SET TO INFUSE AT 250 ML/HR, WHICH SHOULD HAVE INFUSED OVER 4 HOURS, BUT THE IV FLUID RAN THROUGH IN JUST UNDER 2 HOURS. NO HARM TO THE PATIENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7969271 ↗
  • MalfunctionOct 16, 2018Excess Flow or Over-Infusion; Excess Flow or Over-Infusion

    AS REPORTED BY USER FACILITY: EVENT 2- AN "IN HOUSE" TEST OF THE PRODUCT USING A 1 LITER BAG OF FLUID AND THE SAME GRAVITY TUBING THAT IS BEING USED IN THE COMMUNITY WAS PERFORMED. CUSTOMER DID FOLLOW THE DIRECTIONS FOR SET UP OF THE SYSTEM INCLUDING HEIGHT REQUIREMENTS; ETC. THE FLOW REGULATOR WAS SET TO INFUSE AT 250 ML/HR; WHICH SHOULD HAVE INFUSED OVER 4 HOURS, BUT THE IV FLUID RAN THROUGH IN JUST UNDER 2 HOURS. NO PATIENT INVOLVEMENT.

    Patient problems: No Patient Involvement

    MAUDE report 7969268 ↗
  • MalfunctionOct 16, 2018Excess Flow or Over-Infusion; Excess Flow or Over-Infusion

    AS REPORTED BY THE USER FACILITY: EVENT 5. THE FLOW REGULATOR WAS SET TO INFUSE AT 250 ML/HR, WHICH SHOULD HAVE INFUSED OVER 4 HOURS, BUT THE IV FLUID RAN THROUGH IN JUST UNDER 2 HOURS. NO HARM TO THE PATIENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7969267 ↗
  • MalfunctionOct 16, 2018Excess Flow or Over-Infusion; Excess Flow or Over-Infusion

    AS REPORTED BY THE USER FACILITY: EVENT 3. THE FLOW REGULATOR WAS SET TO INFUSE AT 250 ML/HR; WHICH SHOULD HAVE INFUSED OVER 4 HOURS, BUT THE IV FLUID RAN THROUGH IN JUST UNDER 2 HOURS. NO HARM TO THE PATIENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7969265 ↗
  • MalfunctionOct 16, 2018Excess Flow or Over-Infusion; Excess Flow or Over-Infusion

    AS REPORTED BY THE USER FACILITY: EVENT 2. THE FLOW REGULATOR WAS SET TO INFUSE AT 250 ML/HR, WHICH SHOULD HAVE INFUSED OVER 4 HOURS, BUT THE IV FLUID RAN THROUGH IN JUST UNDER 2 HOURS. NO HARM TO THE PATIENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7969264 ↗
  • MalfunctionOct 16, 2018Excess Flow or Over-Infusion; Excess Flow or Over-Infusion

    AS REPORTED BY USER FACILITY: THE FLOW REGULATOR WAS SET TO INFUSE AT 250 ML/HR; WHICH SHOULD HAVE INFUSED OVER 4 HOURS; BUT THE IV FLUID RAN THROUGH IN JUST UNDER 2 HOURS. NO HARM TO THE PATIENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7969263 ↗
  • MalfunctionOct 16, 2018Excess Flow or Over-Infusion; Excess Flow or Over-Infusion

    AS REPORTED BY THE USER FACILITY: EVENT 4- THE FLOW REGULATOR WAS SET TO INFUSE AT 250 ML/HR, WHICH SHOULD HAVE INFUSED OVER 4 HOURS, BUT THE IV FLUID RAN THROUGH IN JUST UNDER 2 HOURS. NO HARM TO THE PATIENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7969261 ↗
  • MalfunctionOct 16, 2018Excess Flow or Over-Infusion; Excess Flow or Over-Infusion

    AS REPORTED BY USER FACILITY: EVENT 1. THE FLOW REGULATOR WAS SET TO INFUSE AT 250 ML/HR, WHICH SHOULD HAVE INFUSED OVER 4 HOURS, BUT THE IV FLUID RAN THROUGH IN JUST UNDER 2 HOURS. NO HARM TO THE PATIENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7969259 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K851058. One submission often covers many models, so check the product and lot details in each record.

  • Z-2601-2011 · Mar 11, 2011 · Terminated
    "***DOSI-FLOW 1 I.V. EXTENSION SET WITH I.V. FLOW REGULATOR REGULADOR DE CAUDAL PARA SETS DE INFUSION I.V.***REF 259-0250***50 UNITS***STERILE OE***LATEX-FREE***LEVENTON LEVENTON,

Other Set, Administration, Intravascular devices

All Set, Administration, Intravascular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page